1. Home
  2. KRYS vs CRL Comparison

KRYS vs CRL Comparison

Compare KRYS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$262.33

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$170.62

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
CRL
Founded
2015
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
7.5B
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
KRYS
CRL
Price
$262.33
$170.62
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$297.60
$200.09
AVG Volume (30 Days)
217.1K
761.0K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
128.00
N/A
EPS
6.84
N/A
Revenue
$389,130,000.00
$1,857,601,000.00
Revenue This Year
$39.88
$0.99
Revenue Next Year
$34.38
$3.26
P/E Ratio
$38.23
N/A
Revenue Growth
33.94
10.48
52 Week Low
$123.03
$91.86
52 Week High
$298.30
$228.88

Technical Indicators

Market Signals
Indicator
KRYS
CRL
Relative Strength Index (RSI) 55.55 51.86
Support Level $251.93 $166.86
Resistance Level $293.60 $182.76
Average True Range (ATR) 9.28 7.16
MACD 2.05 2.30
Stochastic Oscillator 90.05 66.53

Price Performance

Historical Comparison
KRYS
CRL

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: